TrialNaunyn-Schmiedeberg's archives of pharmacology2025

Fenofibrate attenuates doxorubicin-induced cardiotoxicity in patients with breast cancer: a randomized controlled trial.

Hagar K Dewidar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.